San Jose surgical robotics company commercializing the AQUABEAM Robotic System, an FDA-cleared automated robot for BPH via heat-free waterjet ablation.
PROCEPT BioRobotics is a San Jose, California-based surgical robotics company founded in 2007 and publicly traded on Nasdaq under the ticker PRCT since 2021. The company develops and commercializes Aquablation therapy delivered by the AQUABEAM Robotic System, an image-guided surgical robot that combines real-time ultrasound imaging with a robotically controlled, high-velocity sterile saline waterjet to resect prostate tissue in patients with benign prostatic hyperplasia (BPH). Unlike thermal-based procedures, the heat-free waterjet approach reduces the risk of thermal injury and associated side effects.
The system includes the AQUABEAM Console, Conformal Planning Unit, Motorpack, and a single-use disposable Handpiece. It received FDA de novo clearance in 2017 as the first automated surgical robot cleared for BPH treatment and subsequently obtained CE Mark for European markets. The AQUABEAM system is available in both the United States and international markets and is marketed directly to urologists and hospital systems through aquablation.com.
Primary type & automation activities this supplier delivers:
FDA-cleared automated surgical robot delivering Aquablation therapy via image-guided, heat-free high-velocity waterjet for BPH prostate tissue removal.
Contact PROCEPT BioRobotics
WEBSITE
https://www.procept-biorobotics.comPHONE
+1 (650) 232-7200HEADQUARTERS
United States
Company Facts
Founded
2007
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-
Certifications & Memberships